Mirena 52 mg Intrauterine Delivery System
Authorisation PPA0465/292/001 · PCO Manufacturing Ltd.
- Licence holder
- PCO Manufacturing Ltd. (all products →)
- Active substance
- Levonorgestrel
- Clinical trials
- 3 clinical trials →
- Dosage form
- Intrauterine delivery system
- Route of administration
- Intrauterine use
- ATC code
- G02BA03
- First authorised
- 24/08/2012
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Parallel importation notified in accordance with Article 76(3) of Directive 2001/83/EC
Levonorgestrel: supply and approvals
26 authorised products on the HPRA list contain Levonorgestrel. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 21 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 21 Nov 2026)
- Germany (BfArM)
- 2 supply notices, e.g. Levosert 20 Mikrogramm/24 Stunden intrauterines Wirkstofffreisetzungssystem (22 Jun 2026 to 31 Dec 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
Parallel import (PPA). A parallel product authorisation: the HPRA allows this product to be imported from another EU or EEA country and sold in Ireland. It has been authorised for 14 years (since 24 August 2012). The HPRA list does not say whether it is on sale.
Other medicines with Levonorgestrel in Ireland
25 other products on the HPRA list contain Levonorgestrel, from 9 licence holders; 13 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Jaydess 13.5 mg intrauterine delivery system | Bayer Limited | National authorisation (PA) | Marketed |
| Kyleena 19.5 mg intrauterine delivery system | Bayer Limited | National authorisation (PA) | Marketed |
| Leonore 100 micrograms/20 micrograms coated tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Levonorgestrel Rowex 1.5mg Tablet | Rowex Limited, | National authorisation (PA) | Marketed |
| Logynon Tablets | Bayer Limited | National authorisation (PA) | Marketed |
| Logynon Tablets | Bayer Limited | National authorisation (PA) | Marketed |
| Logynon Tablets | Bayer Limited | National authorisation (PA) | Marketed |
| Microlite 100 microgram/20 microgram coated tablets | Bayer Limited | National authorisation (PA) | Marketed |
| Mirena 52 mg intrauterine delivery system | Bayer Limited | National authorisation (PA) | Marketed |
| Ovranette 150 micrograms/30 micrograms coated tablets | Pfizer Healthcare Ireland Unlimited Company | National authorisation (PA) | Marketed |
| Ovreena 30 micrograms/150 micrograms coated tablets | Gedeon Richter Plc | National authorisation (PA) | Marketed |
| Ramonna 1500 microgram Tablet | Gedeon Richter Plc | National authorisation (PA) | Marketed |
The licence holder
PCO Manufacturing Ltd. holds 288 products on the HPRA list, with 164 different active substances; 1 of the products is marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 22 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.